(Total Views: 400)
Posted On: 05/30/2021 12:52:48 PM
Post# of 148928
Seen a lot of posts regarding items like did we define the trials poorly . Ultimately Np and the management team will be evaluated on the success or failure of the Covid strategy in general. if it succeeds even in one country or in the US with LH and it creates significant revenue and gets us on the path to profitability, its successful.
If it fails it will it wont be on initial trial designs as much as it would be, did the management miscalculate the responsiveness of health organizations across the globe, expecting them to be quicker and more flexible during a pandemic. As we have seen so far, these agencies aren't flexible and somewhat stuck in their protocols and paperwork..Hell, even though Pfizer has EUAs in several countries for their vaccine, India was going to make them start a new trial there while they had the worst outbreak in the world currently..they just got this straightened out after about 6 weeks of back and forth..These agencies are locked in their ways and partially responsible for the amount of deaths in the world from Covid..
If it fails it will it wont be on initial trial designs as much as it would be, did the management miscalculate the responsiveness of health organizations across the globe, expecting them to be quicker and more flexible during a pandemic. As we have seen so far, these agencies aren't flexible and somewhat stuck in their protocols and paperwork..Hell, even though Pfizer has EUAs in several countries for their vaccine, India was going to make them start a new trial there while they had the worst outbreak in the world currently..they just got this straightened out after about 6 weeks of back and forth..These agencies are locked in their ways and partially responsible for the amount of deaths in the world from Covid..
(2)
(0)
Scroll down for more posts ▼